The outcome of chemotherapy can be influenced by the host immune system at multiple
levels. Chemotherapy can kill cancer cells by causing them to elicit an immune response or …

As cancer strikes, individuals vary not only in terms of factors that contribute to its occurrence
and development, but as importantly, in their capacity to respond to treatment. While exciting …

Interplay among immune activation and cancer pathogenesis provides the framework for a
novel subspecialty known as immunooncology. In the rapidly evolving field of …

Immunotherapy is a rapidly growing field for cancer treatment. In contrast to conventional
cancer therapies, immunotherapeutic strategies focus on reactivating the immune system to …

Immune cells in the tumor microenvironment have an important role in regulating tumor
progression. Therefore, stimulating immune reactions to tumors can be an attractive …

Over the last few years, several newly developed immune-based cancer therapies have
been shown to induce clinical responses in significant numbers of patients. As a result, there …

Immunotherapy strategies against cancer are emerging as powerful weapons for treatment
of this disease. The success of checkpoint inhibitors against metastatic melanoma and …

Recent technical improvements in evaluations of immune cells in situ and immune
monitoring of patients with cancer have provided a wealth of new data confirming that …

The culmination of over a century's work to understand the role of the immune system in
tumor control has led to the recent advances in cancer immunotherapies that have resulted …

Conventional anticancer therapies, such as chemotherapy, radiotherapy, and targeted
therapy, are designed to kill cancer cells. However, the efficacy of anticancer therapies is not …